Press releases
- Bicycle Therapeutics to Participate in Upcoming Investor Conferences
- Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
- Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
- Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
More ▼
Key statistics
As of last trade Bicycle Therapeutics PLC (50BA:FRA) traded at 21.00, -19.23% below its 52-week high of 26.00, set on Feb 29, 2024.
52-week range
Open | 20.60 |
---|---|
High | 21.00 |
Low | 20.60 |
Bid | 20.80 |
Offer | 21.80 |
Previous close | 21.00 |
Average volume | 967.78 |
---|---|
Shares outstanding | 68.71m |
Free float | 30.27m |
P/E (TTM) | -- |
Market cap | 1.52bn USD |
EPS (TTM) | -4.45 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 14:29 BST.
More ▼